These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31692431)

  • 1. Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI.
    Li J; Sun D; Li Y
    Curr Pharm Des; 2019; 25(35):3726-3739. PubMed ID: 31692431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reperfusion in STEMI patients: still a role for cardioprotection?
    Ottani F; Limbruno U; Latini R; Misuraca L; Galvani M
    Minerva Cardioangiol; 2018 Aug; 66(4):452-463. PubMed ID: 29589674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial reperfusion injury: looking beyond primary PCI.
    Fröhlich GM; Meier P; White SK; Yellon DM; Hausenloy DJ
    Eur Heart J; 2013 Jun; 34(23):1714-22. PubMed ID: 23536610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Heusch G; Gersh BJ
    Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope.
    He J; Bellenger NG; Ludman AJ; Shore AC; Strain WD
    Rev Cardiovasc Med; 2022 Jan; 23(1):23. PubMed ID: 35092215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remote Ischemic Conditioning for Patients With STEMI.
    Schmidt MR; Rasmussen ME; Bøtker HE
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):302-309. PubMed ID: 28381115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection.
    Caricati-Neto A; Errante PR; Menezes-Rodrigues FS
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome.
    Rossello X; Lobo-Gonzalez M; Ibanez B
    Eur Heart J Acute Cardiovasc Care; 2019 Aug; 8(5):443-456. PubMed ID: 31172789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising strategies to minimize reperfusion injury in STEMI.
    Bulluck H; Yellon RL; Yellon DM
    Minerva Cardioangiol; 2016 Jun; 64(3):284-94. PubMed ID: 26859232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic Role of mPTP in Ischemia-Reperfusion Injury.
    Morciano G; Bonora M; Campo G; Aquila G; Rizzo P; Giorgi C; Wieckowski MR; Pinton P
    Adv Exp Med Biol; 2017; 982():169-189. PubMed ID: 28551787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?
    Allencherril J; Alam M; Levine G; Jneid H; Atar D; Kloner RA; Birnbaum Y
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):215-224. PubMed ID: 30563349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.
    Bellis A; Mauro C; Barbato E; Di Gioia G; Sorriento D; Trimarco B; Morisco C
    Cells; 2020 Sep; 9(9):. PubMed ID: 32967374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity as a target for acute cardioprotection.
    Zuurbier CJ; Abbate A; Cabrera-Fuentes HA; Cohen MV; Collino M; De Kleijn DPV; Downey JM; Pagliaro P; Preissner KT; Takahashi M; Davidson SM
    Cardiovasc Res; 2019 Jun; 115(7):1131-1142. PubMed ID: 30576455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
    Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
    Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.
    Hausenloy DJ; Garcia-Dorado D; Bøtker HE; Davidson SM; Downey J; Engel FB; Jennings R; Lecour S; Leor J; Madonna R; Ovize M; Perrino C; Prunier F; Schulz R; Sluijter JPG; Van Laake LW; Vinten-Johansen J; Yellon DM; Ytrehus K; Heusch G; Ferdinandy P
    Cardiovasc Res; 2017 May; 113(6):564-585. PubMed ID: 28453734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reperfusion injury in ST-segment elevation myocardial infarction: the final frontier.
    Ndrepepa G; Colleran R; Kastrati A
    Coron Artery Dis; 2017 May; 28(3):253-262. PubMed ID: 28072597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutic strategies for cardioprotection.
    Sluijter JP; Condorelli G; Davidson SM; Engel FB; Ferdinandy P; Hausenloy DJ; Lecour S; Madonna R; Ovize M; Ruiz-Meana M; Schulz R; Van Laake LW;
    Pharmacol Ther; 2014 Oct; 144(1):60-70. PubMed ID: 24837132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Biomarkers in Acute Myocardial Infarction Before and After Percutaneous Coronary Intervention by Lipidomics Analysis.
    Feng L; Yang J; Liu W; Wang Q; Wang H; Shi L; Fu L; Xu Q; Wang B; Li T
    Med Sci Monit; 2018 Jun; 24():4175-4182. PubMed ID: 29913478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.